Skip to main content
Tech.euFundingExplorerBeta

AdipoPharma

biotech company developing a novel and promising type 2 diabetes drug

AdipoPharma has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Strasbourg, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€0
€0
Funding rounds
1
Investors
2
distinct backers
Active since
2023-01
latest 2023-01

Funding by year

EUR raised per year
AdipoPharma — funding by year — interactive chart.
Data table
AdipoPharma — funding by year
2023€0

Signals

Medium confidence
Raise-next likelihood8
base rate 44% for Series A
  • ▼ Past typical raise window
  • ▼ Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2023-01-23Series A—Good Growth Capital,Newton Biocapital IIView deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData